These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 24723322

  • 1. The 3-NP Model of Striatal Neurodegeneration.
    Brouillet E.
    Curr Protoc Neurosci; 2014 Apr 10; 67():9.48.1-9.48.14. PubMed ID: 24723322
    [Abstract] [Full Text] [Related]

  • 2. The mitochondrial toxin 3-nitropropionic acid induces striatal neurodegeneration via a c-Jun N-terminal kinase/c-Jun module.
    Garcia M, Vanhoutte P, Pages C, Besson MJ, Brouillet E, Caboche J.
    J Neurosci; 2002 Mar 15; 22(6):2174-84. PubMed ID: 11896157
    [Abstract] [Full Text] [Related]

  • 3. Calpain is a major cell death effector in selective striatal degeneration induced in vivo by 3-nitropropionate: implications for Huntington's disease.
    Bizat N, Hermel JM, Boyer F, Jacquard C, Créminon C, Ouary S, Escartin C, Hantraye P, Kajewski S, Brouillet E.
    J Neurosci; 2003 Jun 15; 23(12):5020-30. PubMed ID: 12832525
    [Abstract] [Full Text] [Related]

  • 4. Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats: implications for neuroprotection studies.
    Ouary S, Bizat N, Altairac S, Ménétrat H, Mittoux V, Condé F, Hantraye P, Brouillet E.
    Neuroscience; 2000 Jun 15; 97(3):521-30. PubMed ID: 10828534
    [Abstract] [Full Text] [Related]

  • 5. Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid.
    Guyot MC, Hantraye P, Dolan R, Palfi S, Maziére M, Brouillet E.
    Neuroscience; 1997 Jul 15; 79(1):45-56. PubMed ID: 9178864
    [Abstract] [Full Text] [Related]

  • 6. Effect of rutin against a mitochondrial toxin, 3-nitropropionicacid induced biochemical, behavioral and histological alterations-a pilot study on Huntington's disease model in rats.
    Suganya SN, Sumathi T.
    Metab Brain Dis; 2017 Apr 15; 32(2):471-481. PubMed ID: 27928694
    [Abstract] [Full Text] [Related]

  • 7. 3-Nitropropionic acid induces a spectrum of Huntington's disease-like neuropathology in rat striatum.
    Vis JC, Verbeek MM, De Waal RM, Ten Donkelaar HJ, Kremer HP.
    Neuropathol Appl Neurobiol; 1999 Dec 15; 25(6):513-21. PubMed ID: 10632901
    [Abstract] [Full Text] [Related]

  • 8. Comparison of intrastriatal injections of quinolinic acid and 3-nitropropionic acid for use in animal models of Huntington's disease.
    Shear DA, Dong J, Gundy CD, Haik-Creguer KL, Dunbar GL.
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Oct 15; 22(7):1217-40. PubMed ID: 9829299
    [Abstract] [Full Text] [Related]

  • 9. Structural and functional neuroprotection in a rat model of Huntington's disease by viral gene transfer of GDNF.
    McBride JL, During MJ, Wuu J, Chen EY, Leurgans SE, Kordower JH.
    Exp Neurol; 2003 Jun 15; 181(2):213-23. PubMed ID: 12781994
    [Abstract] [Full Text] [Related]

  • 10. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid.
    Beal MF, Brouillet E, Jenkins BG, Ferrante RJ, Kowall NW, Miller JM, Storey E, Srivastava R, Rosen BR, Hyman BT.
    J Neurosci; 1993 Oct 15; 13(10):4181-92. PubMed ID: 7692009
    [Abstract] [Full Text] [Related]

  • 11. Topological analysis of striatal lesions induced by 3-nitropropionic acid in the Lewis rat.
    Blum D, Gall D, Cuvelier L, Schiffmann SN.
    Neuroreport; 2001 Jun 13; 12(8):1769-72. PubMed ID: 11409756
    [Abstract] [Full Text] [Related]

  • 12. Potential of protease inhibitor in 3-nitropropionic acid induced Huntington's disease like symptoms: mitochondrial dysfunction and neurodegeneration.
    Hariharan A, Shetty S, Shirole T, Jagtap AG.
    Neurotoxicology; 2014 Dec 13; 45():139-48. PubMed ID: 25445565
    [Abstract] [Full Text] [Related]

  • 13. Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease.
    Reynolds DS, Carter RJ, Morton AJ.
    J Neurosci; 1998 Dec 01; 18(23):10116-27. PubMed ID: 9822765
    [Abstract] [Full Text] [Related]

  • 14. The mitochondrial toxin 3-nitropropionic acid induces differential expression patterns of apoptosis-related markers in rat striatum.
    Vis JC, Verbeek MM, de Waal RM, ten Donkelaar HJ, Kremer B.
    Neuropathol Appl Neurobiol; 2001 Feb 01; 27(1):68-76. PubMed ID: 11299004
    [Abstract] [Full Text] [Related]

  • 15. Granulocyte-colony stimulating factor attenuates striatal degeneration with activating survival pathways in 3-nitropropionic acid model of Huntington's disease.
    Lee ST, Park JE, Kim DH, Kim S, Im WS, Kang L, Jung SH, Kim MW, Chu K, Kim M.
    Brain Res; 2008 Feb 15; 1194():130-7. PubMed ID: 18166168
    [Abstract] [Full Text] [Related]

  • 16. Mutant SOD1G93A in bone marrow-derived cells exacerbates 3-nitropropionic acid induced striatal damage in mice.
    Huang QY, Yu L, Ferrante RJ, Chen JF.
    Neurosci Lett; 2007 May 17; 418(2):175-80. PubMed ID: 17418947
    [Abstract] [Full Text] [Related]

  • 17. Probucol increases striatal glutathione peroxidase activity and protects against 3-nitropropionic acid-induced pro-oxidative damage in rats.
    Colle D, Santos DB, Moreira EL, Hartwig JM, dos Santos AA, Zimmermann LT, Hort MA, Farina M.
    PLoS One; 2013 May 17; 8(6):e67658. PubMed ID: 23799154
    [Abstract] [Full Text] [Related]

  • 18. A novel therapeutic application of solid lipid nanoparticles encapsulated thymoquinone (TQ-SLNs) on 3-nitroproponic acid induced Huntington's disease-like symptoms in wistar rats.
    Ramachandran S, Thangarajan S.
    Chem Biol Interact; 2016 Aug 25; 256():25-36. PubMed ID: 27206696
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.